Table 1.
Resting hormone concentration of subjects before each trial
| |
FA |
LA |
FC |
LC |
||||
|---|---|---|---|---|---|---|---|---|
| Subject | [E] (pg/mL) | [P] (ng/mL) | [E] (pg/mL) | [P] (ng/mL) | [E] (pg/mL) | [P] (ng/mL) | [E] (pg/mL) | [P] (ng/mL) |
| 1 |
33.4 |
0.2 |
171.4 |
18.9 |
163.7 |
0.3 |
321.3 |
15.7 |
| 2 |
34.8 |
0.2 |
125.5 |
10.4 |
42.7 |
0.1 |
98.5 |
7.4 |
| 3 |
30.8 |
0.4 |
94.0 |
6.0 |
39.4 |
0.2 |
68.3 |
5.7 |
| 4 |
47.3 |
0.1 |
108.9 |
6.4 |
83.8 |
1.4 |
171.0 |
14.9 |
| 5 |
50.6 |
0.2 |
201.4 |
13.2 |
98.0 |
0.2 |
327.4 |
19.9 |
| 6 |
201.0 |
0.4 |
151.2 |
25.6 |
44.0 |
0.4 |
102.1 |
9.1 |
| mean |
66.3 |
0.3 |
142.1 |
13.4 |
78.6 |
0.4 |
181.4 |
12.1 |
| SD | 66.5 | 0.1 | 40.4 | 7.0 | 48.3 | 0.4 | 115.7 | 5.1 |
Abbreviations: FA follicular phase placebo trial, LA luteal phase placebo trial, FC follicular phase carbohydrate trial, LC luteal phase carbohydrate trial. [E], estradiol concentration, [P] progesterone concentration.